Development of Resistance of Human Immunodeficiency Virus Type 1 to Dextran Sulfate Associated with the Emergence of Specific Mutations in the Envelope gp120 Glycoprotein
- 1 July 1997
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 52 (1) , 98-104
- https://doi.org/10.1124/mol.52.1.98
Abstract
Polyanionic compounds are known to inhibit the binding of human immunodeficiency virus (HIV) to CD4+ cells and the subsequent fusion step between the virus and cells. We selected an HIV-1 strain resistant to dextran sulfate (DS) by cultivation of HIV-1 (NL4–3)-infected MT-4 cells in the presence of DSMr 5000. DS did not inhibit the binding of DS-resistant virus to MT-4 cells or syncytium formation between MOLT cells and HUT-78 cells persistently infected with the DS-resistant virus. In addition, a monoclonal antibody with specificity for the V3 loop of envelope gp120 glycoprotein did not recognize the DS-resistant HIV-1 gp120 V3 loop. The following mutations were found in the gp120 molecule of the DS-resistant HIV-1 strain but not in the wild-type strain: S114N in the V1 loop region; S134N in the V2 loop region; K269E, Q278H, and N293D in the V3 loop region; N323S in the C3 region; a deletion of five amino acids (Phe-Asn-Ser-Thr-Trp) at positions 364–368 in the V4 loop; and R387I in the CD4 binding domain. Our results suggest that (i) DS interacts with specific amino acid residues in the gp120 molecule, (ii) the virus is able to overcome the inhibitory effect of DS on viral infectivity, (iii) cross-resistance developed against those polyanionic compounds that are structurally related to DS, and (iv) the molecular determinants of HIV cell tropism, syncytium-inducing ability, coreceptor (fusin/CC-CKR5) utilization, and polyanion resistance seem to be located in the envgenome of HIV and specifically in the V3 loop domain.Keywords
This publication has 47 references indexed in Scilit:
- The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1Nature, 1996
- Chemokine Receptors and HIV-1: An Attractive Pair?Cell, 1996
- The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after bindingAntiviral Research, 1996
- Antiviral activity of the bicyclam derivative JM3100 against drug-resistant strains of human immunodeficiency virus type 1Antiviral Research, 1996
- Single Basic Amino Acid Substitutions at Position 302 or 320 in the V3 Domain of HIV Type 1 Are Not Sufficient to Alter the Antiviral Activity of Dextran Sulfate and HeparinAIDS Research and Human Retroviruses, 1995
- Influence of host cell type and V3 loop of the surface glycoprotein on susceptibility of human immunodeficiency virus type 1 to polyanion compoundsAntimicrobial Agents and Chemotherapy, 1994
- Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100Antimicrobial Agents and Chemotherapy, 1994
- Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor.Proceedings of the National Academy of Sciences, 1989
- Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virusAntimicrobial Agents and Chemotherapy, 1988
- Dextran Sulfate Suppression of Viruses in the HIV Family: Inhibition of Virion Binding to CD4 + CellsScience, 1988